Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.54 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.54 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | HTR7 | P34969 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22837803 | 0.91 | NAAA (0.51) | CHRNB2CHRNA4NAAAHRH3POLB | |
| SCHEMBL19597610 | 0.80 | NAAA (0.40) | CHRNB2CHRNA4NAAAHTR7POLB | |
| SCHEMBL30339345 | 0.78 | CYP2D6 (0.43) | CHRNB2CHRNA4NAAAHTR7CYP2D6 | |
| SCHEMBL4278696 | 0.78 | CYP2D6 (0.43) | CHRNB2CHRNA4NAAAHTR7CYP2D6 | |
| SCHEMBL4273388 | 0.76 | CYP2D6 (0.54) | NAAAHTR7CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL14300754 | 0.76 | HTR1A (0.39) | NAAAHTR7CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL29415405 | 0.74 | NAAA (0.41) | NAAAHTR7CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL897482 | 0.74 | CYP2D6 (0.49) | NAAAHTR7POLBCYP1A2CYP2D6 | |
| SCHEMBL9459435 | 0.74 | LTA4H (0.37) | NAAAHTR7CYP2D6CYP2C9CYP2C19 | |
| SCHEMBL17672450 | 0.74 | LTA4H (0.37) | NAAAHTR7CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6194416-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE | ELI LILLY AND COMPANY | 2001-02-27 | — | — | US | disclosed |
| US-6187776-B1 | AZACYCLIC-SUBSTITUTED PYRIDINE DERIVATIVES; ALZHEIMER*S DISEASE, SCHIZOPHRENIA, GASTROINTESTINAL DISORDERS; COGNITION ACTIVATORS | ELI LILLY AND COMPANY | 2001-02-13 | — | — | US | disclosed |
| EP-0788489-A4 | HETEROCYCLIC COMPOUNDS AND THEIR USE | LILLY CO ELI (US) | 2000-11-15 | — | — | EP | disclosed |
| US-6071900-A | 2-AZABICYCLOOXYPYRIDAZINES TO TREAT DISEASES IN THE CENTRAL NERVOUS SYSTEM CAUSED BY MALFUNCTIONING OF THE MUSCARINIC CHOLINERGIC SYSTEM; ALZHEIMER'S DISEASE; ANALGESICS; GI AND SLEEPING DISORDERS; GLAUCOMA, PSYCHOSIS, ANTIDEPRESSANTS | ELI LILLY AND COMPANY (US) | 2000-06-06 | — | — | US | disclosed |
| US-6030966-A | FOR TREATING ALZEHIMER'S DISEASE | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5998404-A | NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| US-5998434-A | Composition for treating pain | ELI LILLY AND COMPANY (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0874828-A4 | COMPOSITION FOR TREATING PAIN | LILLY CO ELI (US) | 1999-09-01 | — | — | EP | disclosed |
| US-5888999-A | USING AZACYCLIC AND AZABICYCLIC PYRAZINE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-03-30 | — | — | US | disclosed |
| EP-0874828-A1 | COMPOSITION FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1998-11-04 | — | — | EP | disclosed |
| EP-0788489-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE | ELI LILLY AND COMPANY (US) | 1997-08-13 | — | — | EP | disclosed |
| WO-1997020819-A1 | COMPOSITION FOR TREATING PAIN | ELI LILLY AND COMPANY (US) | 1997-06-12 | — | — | WO | disclosed |
| EP-0773027-A1 | Use of azacyclic or azabicyclic pyrazine compounds for treating anxiety | ELI LILLY AND COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| WO-1996012711-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE | ELI LILLY AND COMPANY (US) | 1996-05-02 | — | — | WO | disclosed |